MedImmune

📍 Gaithersburg, United States🗓 Founded 1987👥 906 employees💰 Last funded 2005
Biotechnology Research🌐 medimmune.com
Website LinkedIn
MedImmune is the global biologics research and development arm of AstraZeneca, a global, innovation-driven biopharmaceutical business that focuses on the discovery, development and commercialization of small molecule and biologic prescription medicines. MedImmune is pioneering innovative research and exploring novel pathways across Oncology, Respiratory, Cardiovascular, Renal and Metabolic Diseases, and Infection and Vaccines. The MedImmune headquarters is located in Gaithersburg, Md., one of AstraZeneca’s three global R&D centres, with additional sites in Cambridge, UK and South San Francisco, CA. For more information, please visit www.medimmune.com
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
1987
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in MedImmune?
MedImmune has 1 investors on record on gritt.io.
When did MedImmune last raise funding?
The most recent investment in MedImmune recorded on gritt.io was in 2005.
When was MedImmune founded?
MedImmune was founded in 1987.
What industry is MedImmune in?
MedImmune operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is MedImmune based?
MedImmune is headquartered in Gaithersburg, United States.